134 related articles for article (PubMed ID: 6377125)
1. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
Wong TM; Chan SH; Tse SY
Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
[TBL] [Abstract][Full Text] [Related]
2. Hypertensive response following stimulation of opiate receptors in the caudal ventrolateral medulla.
Willette RN; Punnen S; Krieger AJ; Sapru HN
Neuropharmacology; 1984 Apr; 23(4):401-6. PubMed ID: 6145114
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular response to injections of enkephalin in the pressor area of the ventrolateral medulla.
Punnen S; Willette R; Krieger AJ; Sapru HN
Neuropharmacology; 1984 Aug; 23(8):939-46. PubMed ID: 6090967
[TBL] [Abstract][Full Text] [Related]
4. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
5. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
Wong-Dusting HK; Rand MJ
Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
[TBL] [Abstract][Full Text] [Related]
6. [D-Ala2]-methionine enkephalinamide reflexively induces antinociception by activating vagal afferents.
Randich A; Maixner W
Pharmacol Biochem Behav; 1984 Sep; 21(3):441-8. PubMed ID: 6494213
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure responses of conscious rats to intravenous administration of enkephalin derivatives (D-ala2 methionine and leucine enkephalinamide, and methionine and leucine enkephalinamide.
Thornhill JA; Saunders WS
Peptides; 1985; 6(6):1253-6. PubMed ID: 3834418
[TBL] [Abstract][Full Text] [Related]
8. Participation of AT1 and AT2 receptors in the differential interaction between angiotensin II or III and alpha-2 adrenoceptors in the nucleus reticularis gigantocellularis in cardiovascular regulation and antinociception in rats.
Yang CH; Shyr MH; Tan PP; Chan SH
J Pharmacol Exp Ther; 1996 Nov; 279(2):795-802. PubMed ID: 8930186
[TBL] [Abstract][Full Text] [Related]
9. Enkephalins induce a centrally mediated rise in blood pressure in rats.
Petty MA; de Jong W
Brain Res; 1983 Feb; 260(2):322-5. PubMed ID: 6299461
[TBL] [Abstract][Full Text] [Related]
10. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy.
Jefferys D; Copolov D; Funder JW
Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
[TBL] [Abstract][Full Text] [Related]
12. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
Agmo A; de Avila N
Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
[TBL] [Abstract][Full Text] [Related]
13. The effect of 17-alpha-estradiol, a possible endogenous opiate antagonist, on D-ala2-met5-enkephalinamide-induced blood pressure responses in conscious, unrestrained rats.
Chandra A; Dixon WR
NIDA Res Monogr; 1986; 75():339-42. PubMed ID: 3123948
[TBL] [Abstract][Full Text] [Related]
14. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
Laurent S; Schmitt H
Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
[TBL] [Abstract][Full Text] [Related]
15. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
Hashimoto K; Suemaru S; Hattori T; Takao T; Inoue H; Sugawara M; Kageyama J; Ota Z
Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557
[TBL] [Abstract][Full Text] [Related]
16. The possible role of opiates in habituation of responses recorded in the reticular formation of the frog, to peripheral stimulation.
Boxer MI
Neurosci Lett; 1983 Sep; 40(1):61-5. PubMed ID: 6605500
[TBL] [Abstract][Full Text] [Related]
17. [D-Ala2]-methionine enkephalinamide (DALA): characterization of antinociceptive, cardiovascular, and autonomic nervous system actions in conscious and pentobarbital-anesthetized rats.
Randich A; Callahan MF
Pharmacol Biochem Behav; 1986 Sep; 25(3):641-50. PubMed ID: 3774831
[TBL] [Abstract][Full Text] [Related]
18. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
Adjroud O
J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
[TBL] [Abstract][Full Text] [Related]
19. Opiate mechanisms in the central amygdala and gastric stress pathology in rats.
Ray A; Henke PG; Sullivan RM
Brain Res; 1988 Feb; 442(1):195-8. PubMed ID: 2834014
[TBL] [Abstract][Full Text] [Related]
20. The effect of intracerebroventricular D-ALA2 methionine enkephalinamide and naloxone on cardiovascular parameters in the cat.
Lathers CM; Tumer N; Kraras CM
Life Sci; 1988; 43(26):2287-98. PubMed ID: 3210904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
